Security key
N71542109
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)
CUSIP: N71542109
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Ordinary Shares, nominal value Euro 0.04 per share
- Total 13F shares
- 44,407,421
- Total 13F value
- $117,680,021
- Share change
- +27,579,306
- Put/Call ratio
- 79%
- SEC-reported price per share
- $2.65
- Number of holders
- 74
- Value change
- +$75,460,221
- Number of buys
- 51
- Number of sells
- 14
- Shares outstanding
- 141,139,908
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
74
Top holders
10
PRQR full security history
Ownership snapshot
Full 13F holder table
ProQR Therapeutics N.V. SEC filings
ProQR Therapeutics N.V. company facts
Broader feeds
Ownership snapshot
Top reported holders of PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Privium Fund Management B.V.
Disclosed value leader
Privium Fund Management B.V.
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 4%
Showing 1-6 of 15 holder rows.
Quick read
Privium Fund Management B.V. leads the comparable SEC ownership view at 4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Privium Fund Management B.V.'s linked filing trail.
Comparable ownership
Top 5
Privium Fund Management B.V.
4%
ADAGE CAPITAL PARTNERS GP, L.L.C.
2.6%
EcoR1 Capital, LLC
1.3%
M28 Capital Management LP
0.72%
DAFNA Capital Management LLC
0.64%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Privium Fund Management B.V. |
13F
Company
|
4%
|
$10,250,946
5,632,388 shares
|
— | 30 Sep 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
2.6%
|
$6,598,350
3,625,467 shares
|
— | 30 Sep 2024 |
| EcoR1 Capital, LLC |
13F
Company
|
1.3%
|
$3,341,504
1,835,991 shares
|
— | 30 Sep 2024 |
| M28 Capital Management LP |
13F
Company
|
0.72%
|
$1,855,486
1,019,498 shares
|
— | 30 Sep 2024 |
| DAFNA Capital Management LLC |
13F
Company
|
0.64%
|
$1,648,159
905,582 shares
|
— | 30 Sep 2024 |
| Ghost Tree Capital, LLC |
13F
Company
|
0.63%
|
$1,615,614
887,700 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
74
Shares
44,407,421
Rows available
74
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
45
Q4 2024 holders
74
Holder diff
29
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|